Clinical and radiologic response in patients with bone metastases managed with combined radiotherapy and bisphosphonates.
Vassiliou
Vassilios
V
Kardamakis
Dimitrios
D
Kalogeropoulou
Christina
C
D000818:Animals; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy*; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D000077557:Ibandronic Acid; D007093:Imidazoles / Q000627:therapeutic use; D010012:Osteogenesis; D010147:Pain Measurement; D000077268:Pamidronate; D018714:Radiotherapy, Adjuvant; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate; D000077557:Ibandronic Acid